Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-00 |
filingDate |
1995-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7b3991f24e8aac2e85290c6ad13f4db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a55c9a029bd81b004e12b129fcd585e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_213f7eeb606f735e3e1a0b773a16c9b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c088db2723ddd8166412223f4aeb828 |
publicationDate |
1996-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2193704-A1 |
titleOfInvention |
New brefeldin a derivatives and their utility in the treatment of cancer |
abstract |
Provided are brefeldin A derivatives of formula (II), wherein one of R1 and R2 is H and the other of R1 and R2 is a substituent group having 1 to 12 carbon atoms containing a basic nitrogen atom or a quaternary ammonium group, or a salt thereof. These derivatives exhibit good antitumor activity, and are administrable to human patients without the problems associated with brefeldin A. |
priorityDate |
1994-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |